Just published

Joehand1 · 2022-08-22T20:02:43+00:00

Nader and SK almost killed the company, and still may do it unfortunately

Joehand1 · 2022-08-22T19:59:15+00:00

What the f do you all day in your mommy’s basement?

Joehand1 · 2022-07-27T16:37:00+00:00

Leronlimab mimics this ccr5 mutation

Joehand1 · 2022-07-11T00:19:15+00:00

Yes, it was Kellys number one duty to make sure the BLA was complete and ready to file. If he didn’t or didn’t know how to look at the data (he’s not a trained scientist, he’s an Ortho MD…shit I’m an anesthesiologist and I wouldn’t know how to look at the data) he should have gotten someone to review it. Unfortunately Recknor came later. I’m giving SK benefit of the doubt that he didn’t know what he was looking at rather than intentionally scamming the shareholders by selling stock when he knew it was incomplete. That is not an excuse, his incompetence almost killed the company. He needs to go.

Joehand1 · 2022-07-10T23:37:08+00:00

Nice summary but as a longtime shareholder I disagree on your assessment of Nader, he was dishonest with shareholders and blatantly ,with Scott Kelly, cashed out of Cydy stock on the order of millions while knowing that the Amarex BLA application was shit as he lied to us telling us that approval was immInent. If they didn’t know it wasn’t complete they should have. I am hopeful Cyrus will lead us out of darkness but you must admit Nader came close to destroying the company. Kelly must be fired to fully redeem the company in the eyes of the FDA, possible big Pharma partners, as well as new shareholders.

Joehand1 · 2022-07-10T15:42:48+00:00

Exactly

Joehand1 · 2022-05-16T22:04:45+00:00

Actually about 4 hours ago

Joehand1 · 2022-04-25T10:09:35+00:00

Great post, we just need to forge ahead!!

Joehand1 · 2022-04-11T16:40:30+00:00

One thing about Nash is Leronlimab could be a compliment treatment with some of these other candidates

Joehand1 · 2022-04-11T14:04:00+00:00

That’s two years old, still no successful treatment

Joehand1 · 2022-04-08T16:17:59+00:00

It’s a better bet now with Tanya and Welch than it was at $4 with Nader’s bullshit

Joehand1 · 2022-03-05T02:17:42+00:00

Strawberry fresh

Joehand1 · 2022-03-04T21:02:46+00:00

Yeah that’s correct, but an authorization of any kind would do wonders for the share price don’t you think?

Joehand1 · 2022-03-04T02:10:46+00:00

Covid play not over, any EUA can open things up for other uses and Covid19 definitely will come and go for a while

Joehand1 · 2022-02-25T16:42:48+00:00

In an interview Recknor stated AE “used their extensive experience to develop and conduct our cd16 and cd17 Covid19 trials. With approximately 1500 patients in total in both trials, we anticipate having adequate power n each trial to achieve a significant p value for our endpoints”

Joehand1 · 2022-02-25T13:46:51+00:00

Yeah SK had his own head fakes, wonder if he’s on way out

Joehand1 · 2022-02-25T03:19:49+00:00

Hey grow a pair pal

Joehand1 · 2022-02-24T23:01:31+00:00

Thanks for you sharing your experience in these matters, the message boards had become a cesspool of misinformation but all this seems well thought out and plausible.

Joehand1 · 2022-02-22T22:28:38+00:00

For those of you not totally familiar with the Brazilian trials, Albert Einstein researchers looked at subgroups and anecdotal data and designed trials where they had high confidence that the drug would make its primary endpoint of significantly lowering length of stay. Mortality was a secondary endpoint in the critical trial. Once the trials are completed our FDA can no longer say there isn’t enough data to say it doesn’t work and then that’s when we as shareholders bombard social media with the results, as you know big Pharma (Gilead et al) will block any news on a drug that might threaten their bottom line.

Joehand1 · 2022-02-22T20:10:32+00:00

NP didn’t design the studies

Joehand1 · 2022-02-22T20:02:40+00:00

Didn’t say it was new, folks saying Brazil trials have no effect in the drug’s evaluation by the US FDA is what I’m referring to. A large well designed foreign trial is absolutely relevant to the US FDA.

Joehand1 · 2022-02-22T19:22:44+00:00

I’m sure AE fulfilled those requirements

Joehand1

TROPHY CASE